Cosmos Study October 14, 2025 Dual-Team Study Team A:Kersten Bartelt, RNEric Barkley Team B:Joel Jones, PharmDJoe Deckert, PhD Key Findings Among non-diabetic patients without chronic kidney disease (CKD), there was a minimal increase of 0.01 mg/dL to 0.02 mg/dL in serum creatinine in the months following initiation of semaglutide, liraglutide, or tirzepatide
(2020) Short chain fatty acids in human gut and metabolic health
For example, a person with HS, type 2 diabetes, and obesity may discuss semaglutide for its labeled metabolic indications while also tracking HS symptoms
Il peptide sembra agire attivando le vie di degradazione proteasomale e riducendo lo stress ossidativo mitocondriale
Additional strategies discussed include: blood sugar stabilization anti-inflammatory nutrition omega-3 fatty acids NAC (N-acetylcysteine) polyphenol-rich foods sleep optimization visceral fat reduction pelvic floor physical therapy nervous system rehabilitation gut healing and microbiome support This Episode Is Brought to You By This episode is brought to you by The Endometriosis Reset , my step-by-step program designed to help women address the full-body drivers of endometriosis symptoms, including inflammation, blood sugar instability, endo belly, fatigue, scar tissue support, and nervous system dysregulation
Is it safe to take sleep medication while on GLP-1 therapy
